Khalis Mustafayev MD, PhD

Thrilled to share that I'll be joining MD Anderson Cancer Center for the Onco-Transplant ID Fellowship starting July 2025 @bcmhouston @MethodistHosp @UTHealthHouston Deepest thanks to my mentors @HarrysTorres01 @BrainTumorDoc and all who believed in me & supported this journey 💙

Grateful to share our work @UTMDAnderson on HCV reactivation in cancer patients with BTK inhibitors, presented at #ESCMIDGlobal2026 in Munich. Thanks to Dr @HarrysTorres01 for his hepatitis expertise! @ASCO @ASH_hematology @AASLDtweets @EASLnews @ESCMID @esgvh_escmid @oncodaily

Congratulations to our @ChemalyRoy @MDAndersonNews for a great presentation today in Munich #ESCMIDGlobal2026 #IDtwitter @IDSAInfo @ESCMID

@Dr_AmerZeidan 😋😋

Simplicity does not rule out heavenly

@eskazanae Allah rahmet eylesin mekanı cennet olsun

tıp fakültesi öğrencisiyken tanıştığım, sonrasında anabilim dalı başkanı iken asistanı olduğum, emekliliği sonrasında da sık sık görüştüğümüz, bir çok öğrenci, hekim ve hastanın hayatına dokunmuş çok sevgili hocam Prof. Dr. Hüsrev Hatemi’yi kaybettik… sayın hocama Allah’tan rahmet, kederli ailesine ve tüm sevenlerine baş sağlığı dilerim. mekanı cennet olsun…

@ziremozay @YaleIMed @neerajaiims @umangtalking @montypal @maughanonc @NazliDizman @ReneeSaliby @huntsmancancer @nsayeghmd @ggebraelmd @LuisMezaco @ZeynepZengin @EbrahimiHedyeh @kor_shah @DrYukselUrun @osutcuoglu @BraunMDPhD Congratulations @ziremozay 💐💐💐

I’m going to Yale!! #Match2026 Still can’t believe I matched at my #1 choice @YaleIMed I'm so grateful to my mentors, friends, and family for supporting me every step of the way and believing in me! @neerajaiims @umangtalking @montypal @maughanonc @NazliDizman @ReneeSaliby

@ZouinaS @JCOOP_ASCO @VivekSubbiah @BrainTumorDoc Congratulations !!

The problem in oncology today isn’t lack of information. It’s too much of it. From information overload → patient-centered care through apomediation. New publication in @JCOOP_ASCO with @VivekSubbiah and @BrainTumorDoc. ascopubs.org/doi/pdf/10.120…

Looking forward to meeting you there! @UTMDAnderson

Reviewing for journals is not easy to fit into our already packed schedules. Remarkable that @crisbergerot @oncoclinicas has been recognized as a top reviewer in not just one, but two journals - @JCOGO_ASCO & @JCOOP_ASCO. Thank you Dr. Bergerot for your tireless efforts in this space!

Honored to be named a 2025 Top Reviewer for @JCOOP_ASCO! Peer review is essential to advancing oncology research, and I am grateful for the opportunity to contribute alongside such dedicated colleagues. Thank you to @jrgralow, @ASCO and the @JCOOP_ASCO team for this recognition⭐️

@nihanakkoc @JCOOP_ASCO @jrgralow @ASCO Congratulations @nihanakkoc 💐💐

Join us in honoring the @JCOOP_ASCO 2025 Top Reviewers! The journal’s quality is built on their rigorous analysis and scientific integrity. We are grateful for the expertise they provide to advance oncology research. Become a reviewer: bit.ly/4l6WGRH

Great session today at the International Clinic @ProjectECHO on Viral Hepatitis @MDAndersonNews. Dr. Puoti from Milan @unimib spoke about #HepC in patients undergoing #HSCT or #SOT @IDSAInfo @AASLDtweets @esgvh_escmid @ESCMID Join us for future sessions mdanderson.org/education-trai…

【Houston collaborative ID core curriculum @TXMedCenter】 SCT, CAR-T therapy, bispecific therapy! @MDAndersonNews presented by Dr. Mulanovich! #IDMedEd #IDFellow #IDCoreCurriculum @IchsGlobal @UT_Infectious @BCMIDFellowship @HMH_IDfellow @MDAndersonNews

Hear from our President @ChemalyRoy as he invites you to engage and network with global leading experts while exploring groundbreaking emerging therapies in the care of immunocompromised patients. @CamilleKotton Register at ichs.org

Mucormycosis is a rapidly progressive, invasive fungal infection that causes severe disease. The latest epidemiologic data, risk factors, diagnostic strategies, and treatment approaches are discussed in a new review. 👉 nej.md/3ZsLZ21 Early diagnosis and initiation of antifungal therapy significantly reduce mortality among patients with mucormycosis and hematologic cancers, from approximately 80% to 40%. Accurate diagnosis of mucormycosis begins at the bedside with evaluation of symptoms and signs in patients at high risk (seen in figure). Although early symptoms and physical findings in patients with mucormycosis are often nonspecific, they carry important diagnostic significance in patient populations with high risk. Periorbital cellulitis, diplopia, focal palatal necrosis, and necrotic wounds in patients at high risk should cause serious concern for mucormycosis and lead to prompt assessment. Maintaining a high index of suspicion for mucormycosis in such patients can be the impetus for obtaining fluids and tissues for diagnostic analysis, ordering imaging procedures, initiating antifungal therapy, requesting surgical assessment, reversing immunodeficiencies, and correcting metabolic abnormalities. Learn more in the Review Article “Mucormycosis” by Dimitrios P. Kontoyiannis, MD, ScD, and Thomas J. Walsh, MD, from the University of Texas M.D. Anderson Cancer Center (@MDAndersonNews), Center for Innovative Therapeutics and Diagnostics, and University of Maryland School of Medicine (@UMmedschool): nej.md/3ZsLZ21

Honored to speak on #HepB and #HepC in Hematopoietic Cell Transplant #HCT at the joint conference between @esgvh_escmid and the Turkish Society of Infectious Diseases in Ankara, Türkiye @MDAndersonNews @klimik_dernegi @IDSAInfo @cdchep @EASLnews @AASLDtweets @ASTCT @ESCMID

@Sarbaji85064063 @AzzaSarfraz @MiamiCancerInst @ASCO @NANETS1 Congratulations 👏👏

Congratulations to @AzzaSarfraz for her first presentation since joining @MiamiCancerInst. Many more to come! @ASCO @NANETS1

Survival and Treatment Outcomes of SCLC Patients with Brain Metastases - @drxalis oncodaily.com/voices/khalis-… #Cancer #Oncology #OncoDaily #Health #Medicine @CancerWorldmag

@hatice_bolek @myESMO @AUTF_DEKANLIK @DrYukselUrun @yekeduz_emre Congratulations 👏👏

Happy to share that I passed the @myESMO Examination 2025 among the Top 5 performers and was included in the ESMO Exam Talent Pool 🎉 I would like to sincerely thank my mentors at @AUTF_DEKANLIK for their invaluable support throughout my education. @DrYukselUrun @yekeduz_emre

@eskazanae Tebrikler abi 👏👏👏

93 yılında öğrenci olarak adım attığım Cerrahpaşa Tıp Fakültesi’nin, Hematoloji bilim dalına bugün başkan seçildim 🥰 tüm hocalarıma çok teşekkür ediyorum, umarım güvenlerine layık olabilirim ☺️ üzerimde emeği olan tüm hocalarıma ve geçmiş bilim dalı başkanlarımıza en derin saygılarımı sunarım, vefat eden hocalarımızın da mekanı cennet olsun. hep birlikte CTF Hematoloji’yi çok daha iyi yerlere çıkaracağımıza eminim 🤗🧿